KCPG
BSX.PRA

Kavar Capital Partners Group’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Kavar Capital Partners Group’s Portfolio BSX.PRA Stock Details BSX.PRA Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6,200
Closed -$629K – 166
2022
Q2 		$629K Buy
+6,200
New +$629K 0.15% 97
2020
Q4 		– Sell
-4,100
Closed -$459K – 156
2020
Q3 		$459K Buy
+4,100
New +$459K 0.15% 100